Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
September 22 2023 - 7:55AM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE
13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
September, 2023
Commission File Number 1-15182
DR.
REDDY’S LABORATORIES LIMITED
(Translation of registrant’s name into English)
8-2-337, Road No. 3, Banjara Hills
Hyderabad, Telangana 500 034, India
+91-40-49002900
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form
20-F x Form
40-F ¨
Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(1): ______
Note: Regulation S-T Rule 101(b)(1) only permits the submission
in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.
Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(7): ______
Note: Regulation S-T Rule 101(b)(7)
only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private
issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized
(the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities
are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the
registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other
Commission filing on EDGAR.
Indicate by check mark whether by furnishing
the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b)
under the Securities Exchange Act of 1934.
Yes
¨ No
x
If “Yes” is marked, indicate below the file number assigned
to registrant in connection with Rule 12g3-2(b): 82-________.
EXHIBITS
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
DR. REDDY’S LABORATORIES LIMITED
(Registrant) |
|
|
|
Date: September 22, 2023 |
By: |
/s/ K Randhir Singh |
|
|
Name: K Randhir Singh |
|
|
Title: Company Secretary |
Exhibit
99.1
![](https://www.sec.gov/Archives/edgar/data/1135951/000157587223001469/drr0519_ex99-1img01.jpg) |
Dr.
Reddy’s Laboratories Ltd.
8-2-337,
Road No. 3, Banjara Hills,
Hyderabad
- 500 034, Telangana,
India.
CIN
: L85195TG1984PLC004507
Tel :
+91 40 4900 2900
Fax :
+91 40 4900 2999
Email
: mail@drreddys.com
www.drreddys.com |
September
22, 2023
National
Stock Exchange of India Ltd. (Stock Code: DRREDDY-EQ)
BSE
Limited (Stock Code: 500124)
New
York Stock Exchange Inc. (Stock Code: RDY)
NSE
IFSC Ltd. (Stock Code: DRREDDY)
Sub:
Intimation regarding Board Meeting
Dear
Sir/Madam,
Pursuant
to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we
hereby intimate you that a meeting of the Board of Directors of the Company will be held on Friday, October 27, 2023, inter alia, to
consider and approve the Unaudited Financial Results of the Company for the quarter and half year ending on September 30, 2023.
Further,
kindly note that, under the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and Code of Conduct to Regulate,
Monitor and Report Trading by Designated Persons, the trading window for dealing in securities of the Company will be closed from September
24, 2023, to October 29, 2023 (both days inclusive).
This
is for your information and records.
Thanking
you.
Yours
faithfully,
For
Dr. Reddy’s Laboratories Limited
![](https://www.sec.gov/Archives/edgar/data/1135951/000157587223001469/drr0519_ex99-1img02.jpg)
K
Randhir Singh
Company
Secretary, Compliance Officer and Head CSR
Dr Reddys Laboratories (NYSE:RDY)
Historical Stock Chart
From Jun 2024 to Jul 2024
Dr Reddys Laboratories (NYSE:RDY)
Historical Stock Chart
From Jul 2023 to Jul 2024